Daily Market Commentary for February 19, 2014

Chelsea Therapeutics International Ltd. (CHTP-Nasdaq) received approval Tuesday, from the U.S. Food and Drug Administration for Northera capsules (droxidopa) to be used for the treatment of neurogenic orthostatic hypotension (NOH).

read more at:http://www.millennium-traders.com/news/newscommentary.aspx


Thanks for reading
Millennium-Traders.Com
http://www.millennium-traders.com